Objective To delineate the characteristics and clinical significance of plasma inflammatory
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …

Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …

Despite extensive research to decipher the immunological basis of coronavirus disease
(COVID-19), limited evidence on immunological correlates of COVID-19 severity from MENA …

Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, it has rapidly
spread across many other countries. While the majority of patients were considered mild …

Objective Most patients infected with the novel coronavirus (SARS‐CoV‐2), as the causative
agent of COVID‐19 disease, show mild symptoms, but some of them develop severe illness …

Background The severe manifestation of coronavirus disease 2019 (COVID-19) is known to
be mediated by several cytokines and chemokines. The study aimed to compare the early …

Immune dysregulation is a key feature of the coronavirus disease-2019 (COVID-19).
However, disparities in responses across ethnic groups are underappreciated. This study …

Coronavirus disease 2019 (COVID-19) broke out and then became a global epidemic at the
end of 2019. With the increasing number of deaths, early identification of disease severity …

Background. Tissue damage caused by COVID‐19 could be detected by several clinical
indicators including hematological, immunological, biochemical, and inflammatory markers …

Background To evaluate the ability of peripheral blood inflammatory markers in predicating
the typing of COVID‐19, prognosis, and some differences between COVID‐19 and influenza …